BridgeBio Pharma Inc

Company Snapshot
421 Kipling Street
Palo Alto, CA 94301
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 248
https://www.bridgebio.com
Please select from the dropdown
Company Financials

2019
2020
2021
Gross Profit
$38,060,000
$8,249,000
$66,602,000
Operating Income
($266,240,000)
($474,482,000)
($576,632,000)
Net Income
($260,587,000)
($448,724,000)
($562,539,000)
2019
Gross Profit
$38,060,000
Operating Income
($266,240,000)
Net Income
($260,587,000)
2020
Gross Profit
$8,249,000
Operating Income
($474,482,000)
Net Income
($448,724,000)
2021
Gross Profit
$66,602,000
Operating Income
($576,632,000)
Net Income
($562,539,000)
The above data on BridgeBio Pharma Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Neil Kumar
Director; President and Chief Executive Officer of the company and Eidos Therapeutics
$725,000
$24,869,101
$32,858
$25,626,959
Neil Kumar
$25,626,959
Director; President and Chief Executive Officer of the company and Eidos Therapeutics
Brian Stephenson
Chief Financial Officer and Principal Accounting Officer
$825,000
$7,840,697
$11,600
$8,677,297
Brian Stephenson
$8,677,297
Chief Financial Officer and Principal Accounting Officer
Charles Homcy
Lead Director and Chairman of Pharmaceuticals
$50,000
$2,309,354
$511,600
$2,870,954
Charles Homcy
$2,870,954
Lead Director and Chairman of Pharmaceuticals
Richard Scheller
Chairman of Research and Development and Director
$50,000
$2,049,978
$502,400
$2,602,378
Richard Scheller
$2,602,378
Chairman of Research and Development and Director
James Momtazee
Director and Senior Advisor, Transactions
$50,000
$1,199,989
$4,334
$1,254,323
James Momtazee
$1,254,323
Director and Senior Advisor, Transactions
BridgeBio Pharma Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2021. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us